SCHEMBL5690284

SCHEMBL5690284

Cc1ccnc(CCc2ccc(OC(=O)N3CCC(COc4ccc(C(=O)O)cc4)CC3)cc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 1/20 0.43
HDAC1 Q13547 1/20 0.42
KCNH2 Q12809 2/20 0.41
HTR4 Q13639 1/20 0.41
SSTR5 P35346 1/20 0.41
KDM5A P29375 1/20 0.40
KDM2B Q8NHM5 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
KDM5B Q9UGL1 1/20 0.40
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
NOS2 P35228 1/20 0.39
MGLL Q99685 2/20 0.38
SLC2A1 P11166 1/20 0.38
CYP4F2 P78329 1/20 0.38
CYP4A11 Q02928 1/20 0.38
CHEK2 O96017 3/20 0.38
FAAH O00519 1/20 0.38
NPY2R P49146 1/20 0.38
TLR9 Q9NR96 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5687640 0.92 GRIN2B (0.43) GRIN2BHDAC1KCNH2SSTR5KDM5A
SCHEMBL5931437 0.91 GRIN2B (0.43) GRIN2BHDAC1NOS3NOS1NOS2
SCHEMBL5688596 0.88 SRD5A2 (0.44) KCNH2SSTR5NOS3NOS1NOS2
SCHEMBL5688089 0.86 GRIN2B (0.43) GRIN2BHDAC1KCNH2HTR4SSTR5
SCHEMBL5931976 0.85 LIPE (0.47) GRIN2BHDAC1MGLLCYP4F2CYP4A11
SCHEMBL5931870 0.85 LIPE (0.44) GRIN2BMGLLCYP4F2CYP4A11
SCHEMBL5689825 0.84 KCNH2 (0.42) GRIN2BKCNH2HTR4SSTR5MGLL
SCHEMBL5687988 0.83 GRIN2B (0.43) GRIN2BHDAC1NOS3NOS1NOS2
SCHEMBL5688040 0.82 GRIN2B (0.42) GRIN2BHDAC1NOS3NOS1NOS2
SCHEMBL5687268 0.82 GRIN2B (0.45) GRIN2BHDAC1KCNH2HTR4SSTR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160851-A1 Substituted piperidine carbamates NOVO NORDISK A/S (DK) 2006-07-20 US claimed
CN-1805951-A Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase NOVO NORDISK AS (DK) 2006-07-19 CN claimed
EP-1636207-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2006-03-22 EP claimed
WO-2004111032-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-12-23 WO claimed
US-20060160851-A1 Substituted piperidine carbamates NOVO NORDISK A/S (DK) 2006-07-20 US disclosed
CN-1805951-A Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase NOVO NORDISK AS (DK) 2006-07-19 CN disclosed
EP-1636207-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2006-03-22 EP disclosed
WO-2004111032-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160851-A1 Substituted piperidine carbamates LIPE, PNLIP, LIPC GRIN2B 2588/4885HDAC1 161/4885KCNH2 2290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.